期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

基质金属蛋白酶及其组织抑制物在子宫内膜癌中的表达 被引量：1

Expression of matrix metalloproteinase-9 and it's tissue inhibitor-1 in endometrial carcinoma
下载PDF
导出
摘要 目的 研究基质金属蛋白酶（MMP）-9及其组织抑制物（TIMP）-1在子宫内膜癌组织中的表达及其临床病理学意义。方法 应用链霉素抗生物素蛋白-过氧化物酶免疫组织化学方法对40例子宫内膜癌组织及10例正常子宫内膜组织中MMP-9及TIMP-1蛋白及活性进行检测。结果 子宫内膜癌组织中MMP-9及TIMP-1的阳性率高于正常子宫内膜，差异有显著性。组织学分级为C3的子宫内膜癌组织中MMP-9和TIMP-1的表达水平高于C2和G1，手术病理分期Ⅱ-Ⅲ期的子宫内膜癌组织中MMP-9和TIMP-1的表达水平高于Ⅰ期。结论 子宫内膜癌组织中MMP-9和TIMP-1的表达随着组织学分级和手术病理分期的升高而增加。 Objective To study the expression of matrix metalloproteinase （MMP） - 9 and tissue inhibitor of metalloproteinase （TIMP） - 1 protein in human endometrial carcinoma tissue and its corelation with clinicopathologicol features. Methods Imrnunohistochemistry technique was used to measure the MMP-9 and TIMP - 1 protein levels and activities in endometrial carcinoma tissue of 40 patients and control group composed of 10 normal endometrial samples. Results The positive expression of MMP- 9 and TIMP - 1 proteins in endometrial carcinoma tissue were higher than those in normal endometrial samples. MMP - 9 and TIMP-1 expression levels in grade Ⅲ carcinoma tissues were higher than those in grade Ⅱ- and Ⅰ . They were also higher in stage Ⅱ- and Ⅲ carcinoma tissues than those in stage Ⅰ . Conclusion MMP - 9 and TIMP - 1 expression levels in endometrial carcinoma correlate with the histologic grade and surgical - pathological stage.
作者 黄素真 罗湘闽 吴春林 黄种心
机构地区 福建医科大学附属二院妇产科 福建医科大学附属二院病理科
出处 《实用肿瘤学杂志》 CAS 2006年第3期190-192,共3页 Practical Oncology Journal
关键词 子宫内膜肿瘤 基质金属蛋白酶类 基质金属蛋白酶类抑制剂 Endometrial neoplasms Matrix metalloproteinases Tissue inhibitor of metalloproteinases
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献9

  • 1Okada A.Roles of matrix metalloproteinases and tissue inhibitor of metalloproteinase (TIMP) in cancer invasion and metastasis[J].Gan To Kagakn Ryoho,1999;26(14):2247～2252.
  • 2Maatta M,Soini Y,Liakka A,et al.Localization of MT1-MMP,TIMP-1,TIMP-2,and TIMP-3 messenger RNA in normal,hyperplastic,and neoplastic endometrium.Enhanced expression by endometrical adenocarcinomas is associated with low differentiation[J].Am J Clin Pathol,2000;114(3):402～411.
  • 3Inrlaro M,Loverro G,Vacca A,et al.Angiogensis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma[J].Eur J Clin Invest,1999;29(9):793～801.
  • 4Di Nezza LA,Misajon A,Zhang J,et al.Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion[J].Cancer,2002;94(5):1466～1475.
  • 5Ueno H,Yamashita K,Azumano I,et al.Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas[J].Int J Cancer,1999;84(5):470～477.
  • 6Moci T,Nakahashi K,Kyokuwa M,et al.A matrix metalloproteinase inhibitor,ONO-4817,retards the development of mammary tumor and the progression of uterine adenomyosis in mice[J].Anticancer Res,2002;22(6):3985～3988.
  • 7Liu J,Tsao MS,Pagura M,et al.Early combined treatment with corboplatin and the MMP inhibitor,prinomastat,prolongs survival and reduces systemic metastasis in an aggressive orthotopic lung cancer model[J].Lung Cancer,2003;42(3):335～344.
  • 8Shi Y,Parhar RS,Zou M,et al.Gene therapy of melanoma pulmonary metastasis by intramuscular injection of plasmid DNA encoding tissue inhibitor of metalloproteinases-1[J].Cancer Gene Ther,2002;9(2):126～132.
  • 9Tran PL,Vigneron JP,Pericat D,et al.Gene therapy for hepatocellular carcinoma using non-viral rectors composed of bis gnanidinium-trencholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3[J].Cancer Gene Ther,2003;10(6):435～444.

同被引文献10

  • 1高宝辉,谢丽微,祁旦已,赵志光,谢小志,王宗敏.MMP-7、MVO在子宫内膜样腺癌中的表达[J].实用肿瘤学杂志,2004,18(5):343-346. 被引量：3
  • 2Vuth, Werb Z. Matrix metal oproteinases : effectors of devel- opment and normal physiology [ J ]. Genes Dev, 2000, 14 (17) :2123 - 2133.
  • 3Sternlieht MD, Werb Z. How matrix metalloproteinases regu- late cell behavior [ J]. Annu Rev Cell Dev Biol,2001,17: 463- 516.
  • 4Ajisaka H, Yonemura Y, Miwa, K. Correlation of lymphnode metastases and expression of matrix metalloproteinase - 7 in patients with gastric cancer [ J ]. Hepatogastroenterology, 2004,51:900 - 905.
  • 5Gemasa K,Tanimoto H, Sakata K, et al. Induction of matrix metalloprotease- 7 is common in mucinous ovarian tumorsincluding early stage disease [ J ]. Med Oncol, 2000,17 : 52 - 58.
  • 6Yurchenco PD, Schittny JC. Molecular architecture of base- mentm embranes [ J ]. FASEB J, 1990,4 (6) : 1577.
  • 7Curran S, Murray GJ. Matrix metallo proteinases in tumor in- vasion and metastasis [ J ]. J Patho, 1999,189 ( 3 ) : 300.
  • 8Knox JD, Boreham DR, Walker JA, et al. Mapping of the metalloproteinase gene matrilysin ( MMP - 7 ) to humanchromosomel lq21 - q22 [ J ]. Cytogen Cell Genet, 1996, 72: 179- 182.
  • 9Noev, Fingleton B, Jacobs K, et al. Release of an invasion promoter E - cadherin fragment by matrilysin and stromel- ysin- l[J].Cell. Sci,2001,114: 111- 118.
  • 10Powell WC, Fingleton B, Wilson CL, et al. The metallopro- teinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis [ J ]. Curr. Bio1,1999,9:1441 - 1447.

引证文献1

二级引证文献1

实用肿瘤学杂志
2006年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部